A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial
Resource Type
Article
Authors
Peters, Solange ; Danson, Sarah ; Hasan, Baktiar ; Dafni, Urania ; Reinmuth, Niels ; Majem, Margarita ; Tournoy, Kurt G. ; Mark, Michael T. ; Pless, Miklos ; Cobo, Manuel ; Rodriguez-Abreu, Delvys ; Falchero, Lionel ; Moran, Teresa ; Ortega Granados, Ana Laura ; Monnet, Isabelle ; Mohorcic, Katja ; Sureda, Bartomeu Massutí ; Betticher, Daniel ; Demedts, Ingel ; Macias, Jose Antionio ; Cuffe, Sinead ; Luciani, Andrea ; Sanchez, Jose Garcia ; Curioni-Fontecedro, Alessandra ; Gautschi, Oliver ; Price, Gillian ; Coate, Linda ; von Moos, Roger ; Zielinski, Christoph ; Provencio, Mariano ; Menis, Jessica ; Ruepp, Barbara ; Pochesci, Alessia ; Roschitzki-Voser, Heidi ; Besse, Benjamin ; Rabaglio, Manuela ; O’Brien, Mary E.R. ; Stahel, Rolf A.
Source
In Journal of Thoracic Oncology October 2020 15(10):1647-1656
Subject
Language
ISSN
1556-0864